Loading TrenasCycles…
Peptides / long-acting GHRH analog
CJC 1295
CJC-1295 is marketed for muscle growth and recovery through higher growth hormone and IGF-1. The long-acting DAC form raises those hormones for days, but that has not proven better gym results. No-DAC products can be a different peptide, so the names are not interchangeable. Heart-rate or circulation reactions, immune concerns and uncertain product quality are the main risks.
Small human studies measured prolonged hormone changes, but did not establish bodybuilding results, clinical benefit or long-term safety.
Water retention, flushing, headache, numbness or joint symptoms, glucose effects, and injection, sterility and unregulated-product risks.
Glucose, edema, neurologic or joint symptoms, injection sites and IGF-1 where clinically appropriate.
Not approved for bodybuilding or general anti-aging use. CJC-1295 with DAC is not identical to shorter-acting modified GRF 1-29 products.
Other aliases: CJC 1295 · CJC-1295 with DAC · DAC:GRF
Small studies found prolonged GH and IGF-1 elevation after CJC-1295.
Hormone changes do not establish bodybuilding results or long-term clinical safety.
Original source ↗Measured continued pulsatile GH secretion during prolonged stimulation by long-acting CJC-1295.
Did not test physique outcomes, functional benefit or long-term safety.
Original source ↗